A phase 1 study of nivolumab in combination with ipilimumab for relapsed or refractory hematologic malignancies (CheckMate 039) Meeting Abstract


Authors: Ansell, S.; Gutierrez, M. E.; Shipp, M. A.; Gladstone, D.; Moskowitz, A.; Borello, I.; Popa-Mckiver, M.; Farsaci, B.; Zhu, L.; Lesokhin, A. M.; Armand, P.
Abstract Title: A phase 1 study of nivolumab in combination with ipilimumab for relapsed or refractory hematologic malignancies (CheckMate 039)
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394446803143
PROVIDER: wos
Notes: Meeting Abstract: 183 -- Source: Wos
MSK Authors
  1. Alison Moskowitz
    136 Moskowitz
  2. Alexander Meyer Lesokhin
    106 Lesokhin